Clinical Trials Logo

Blood Pressure clinical trials

View clinical trials related to Blood Pressure.

Filter by:

NCT ID: NCT04098978 Completed - Hypertension Clinical Trials

Before-after Comparison of Pharmacist Drug Therapy Management in Pediatric Hypertension

Start date: January 14, 2020
Phase: N/A
Study type: Interventional

This study will measure the effect of a novel pharmacy practice model on pediatric patients with hypertension. In North Louisiana, many patients have to travel to see subspecialists for treatment for hypertension and elevated blood pressure, which has many costs including direct medical costs, direct nonmedical costs, and indirect costs like missed time from work, school, or social obligations. Also, many patients who have to travel to get to their appointments have a high rate of missed appointments, which can be bad for overall health. This study will use a pharmacist to perform collaborative drug therapy management with pediatric cardiologists to manage therapy for patients with hypertension or elevated blood pressure. Patients will monitor blood pressure at home and follow up with the pharmacist by telecommunications. Pharmacist drug therapy management and telemedicine have been studied separately, but this is the first study with pharmacist drug therapy management by telemedicine for pediatric patients. If this model is successful, it could be replicated in other rural areas to improve patient care and reduce healthcare costs.

NCT ID: NCT04084847 Completed - Blood Pressure Clinical Trials

Berberis Vulgaris Consumption and Blood Pressure

Start date: September 18, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of barberry consumption on systolic and diastolic blood pressure, serum lipids, and inflammatory status. The study will involve cases having elevated BP (129/ < 85) and known hypertensive patients on medical treatment. Seventy people will be randomized into two groups, including intervention (barberry) or placebo groups. Before and after of 8 week intervention, 24-hour ambulatory blood pressure monitoring will be done and fasting venous blood sample will be taken to measure plasma lipids. In addition, 24-hour urine will be collected to measure its sodium content and estimate sodium intake.

NCT ID: NCT04082819 Completed - Hypertension Clinical Trials

MediBeat - HeartBeat Observation Trial

Start date: October 4, 2019
Phase: N/A
Study type: Interventional

The goal of the study was to compare the current gold standard blood pressure instrument (a mercury-filled sphygmomanometer with cuff and stethoscope) with the new experimental algorithm developed by HeartBeat Technologies Ltd. To that end, participants were recruited from Markham, Ontario and participated in a series of alternating blood pressure measurements over a period of 45 minutes. Comparisons were made between manual measurements and device measurements to determine the quality of the device readings. Measurements were taken by trained nurses and staff were consistent across the study duration.

NCT ID: NCT04057495 Completed - Blood Pressure Clinical Trials

The Acute Effect of Mango Intake (Mangifera Indica L.) on Blood Pressure and Blood Glucose

Start date: November 11, 2019
Phase: N/A
Study type: Interventional

In the current proposal the investigators seek to evaluate the acute effects of mango intake on blood pressure, blood glucose and insulin in postmenopausal women between 50 and 70 years old.

NCT ID: NCT04050332 Completed - Physical Activity Clinical Trials

Can RFID Technology Capture Stair Walking

Start date: October 16, 2019
Phase: N/A
Study type: Interventional

There are two main aims for this study: 1. conduct a proof-of-concept study illustrating how radio-frequency identification technology can be used to document the timestamps and duration of stair walking (ascending and descending stairs), and detect if an individual is stationary in the stairwell. 2. assess the association of a 4-min bout of self-paced stair walking with changes in blood pressure, mood, and perceived exertion.

NCT ID: NCT04049162 Completed - Clinical trials for Overweight and Obesity

Blueberry Enhances Activity and Cognition Through Increased Vascular Efficiency

BEACTIVE
Start date: September 20, 2019
Phase: N/A
Study type: Interventional

Recent evidence suggests that increased berry intake results in a variety of health benefits, across multiple health domains. This 3-month randomized, double-blind, placebo-controlled trial assess the effects of combining daily blueberry intake with weekly exercise (BB-EX) on cardiovascular function, as well as physical activity and cognitive function, in sedentary older adults (>60 years). We will compare these effects to the same outcomes with a control group consuming a blueberry placebo (P-EX) at 0, 4, 8 and 12 weeks.

NCT ID: NCT04044638 Completed - Blood Pressure Clinical Trials

Eight Week Strength Training Reduces Blood Pressure of Middle Age Women

Start date: March 5, 2018
Phase: N/A
Study type: Interventional

Introduction: Strength training (ST) is an important non-pharmacological means to reduce blood pressure (BP). Objective: To verify the pressure response of women after 8 weeks of ST. Method: Fourteen women were divided into young group (YG) and middle age (MAG) and submitted to ST for 8 weeks, lasting 60 minutes in 11 alternating exercises per segment with intensity of 12 to 13 on the subjective perception scale of effort. BP was verified at weeks 1, 4 and 8.

NCT ID: NCT04031768 Completed - Hypertension Clinical Trials

Best Rest: Rest Time Before Blood Pressure Measurement Trial

Start date: November 11, 2019
Phase: N/A
Study type: Interventional

The objectives of this study are to: 1. Determine the impact of wait time before initiating BP measurement on BP variability 2. Determine the difference in BP variability between measurements by amount of initial rest. The investigators also aim to: 1. To determine the total time required to obtain a BP measurement.

NCT ID: NCT04024852 Completed - Blood Pressure Clinical Trials

Air Pollution, Physical Activity and Cardiovascular Function of Patients With Implanted Cardioverter Defibrillators

Start date: May 30, 2016
Phase: N/A
Study type: Interventional

This study investigated whether patients with an implanted cardioverter defibrillator (ICD) who followed advice to exercise indoors on high air pollution days had reduced adverse impacts on cardiovascular measures compared with those who exercised outdoors on those days. Participants were randomly divided into the control and intervention groups. Both groups walked for 30 minutes outdoors every day for maximum 70 days, and their blood pressure, pulse rate and blood oxygen saturation pre- and post-exercise were measured. Hourly ambient concentrations of air pollutants were collected. On days forecast with Air Quality Health Index was equal to or higher than 5, the intervention group was advised to exercise indoors.

NCT ID: NCT04017039 Completed - Sleep Clinical Trials

Sleep, Blood Pressure and Vascular Health

Start date: November 10, 2016
Phase: N/A
Study type: Interventional

The investigators hypothesize that chronic insufficient sleep is associated with diminished endothelium-dependent nitric oxide-mediated vasodilation and endothelial tissue-type plasminogen activator release in adults with elevated blood pressure. Furthermore, the investigators hypothesize that the postulated diminishment in endothelial vasodilator and fibrinolytic function with insufficient sleep will be due, at least in part, to increased oxidative stress. Furthermore, increasing sleep duration and improving sleep quality will increase both endothelium-dependent nitric oxide-mediated vasodilation and endothelial tissue-type plasminogen activator release in adults with elevated blood pressure. Increases in endothelial vasodilator and fibrinolytic function will be due, at least in part, to reduced oxidative stress.